| __timestamp | Agios Pharmaceuticals, Inc. | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 2652041 |
| Thursday, January 1, 2015 | 35992000 | 2361587 |
| Friday, January 1, 2016 | 50714000 | 4472869 |
| Sunday, January 1, 2017 | 71124000 | 5030957 |
| Monday, January 1, 2018 | 114145000 | 4988941 |
| Tuesday, January 1, 2019 | 132034000 | 5196412 |
| Wednesday, January 1, 2020 | 149070000 | 6652774 |
| Friday, January 1, 2021 | 121445000 | 18418247 |
| Saturday, January 1, 2022 | 121673000 | 24827066 |
| Sunday, January 1, 2023 | 119903000 | 41896408 |
| Monday, January 1, 2024 | 156784000 | 15488619 |
Unlocking the unknown
In the competitive landscape of the pharmaceutical industry, understanding spending patterns is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Opthea Limited and Agios Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Agios Pharmaceuticals consistently outspent Opthea, with its SG&A expenses peaking in 2020 at approximately 149 million USD. In contrast, Opthea's highest expenditure was in 2023, reaching around 42 million USD, marking a significant increase of over 500% from its 2014 figures.
These trends highlight the differing strategic priorities and growth trajectories of these two companies.
Breaking Down SG&A Expenses: Eli Lilly and Company vs Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: Sanofi vs Opthea Limited Trends and Insights
Operational Costs Compared: SG&A Analysis of Bristol-Myers Squibb Company and Agios Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Gilead Sciences, Inc. and Opthea Limited
Genmab A/S and Opthea Limited: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Pharming Group N.V. and Opthea Limited
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: Madrigal Pharmaceuticals, Inc. vs Opthea Limited Trends and Insights
Opthea Limited vs Alpine Immune Sciences, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Opthea Limited and Mesoblast Limited
Cost Management Insights: SG&A Expenses for Xenon Pharmaceuticals Inc. and Agios Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.